Silva, G., Sales-Dias, J., Casal, D., Alves, S., Domenici, G., Barreto, C., . . . Barbas, A. (2021). Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer.
Citação do estilo Chicago (17ª ed.)Silva, G., et al. Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy Against Estrogen Receptor-Positive Breast Cancer. 2021.
Citação MLA (8ª ed.)Silva, G., et al. Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy Against Estrogen Receptor-Positive Breast Cancer. 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.